4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-035548
Director sold 46,763 shares at an average $60.11 ($2,811,048)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…